Top Keywords: itp, refractory, cell, car t, car, sunact, t cell, therapy, cell therapy, t cell therapy, cells, car t cell, cancer, car t cell therapy, thrombocytopenia, t, refractory itp, immune thrombocytopenia, therapies, immune, reprogramming, immunity, a, conquer, autoimmune, t cells, cd19, treatment, immune thrombocytopenia itp, cancer therapies, advanced cancer, car t cells, advanced, q, y, case, Theres a total of 817 keywords.

Statistics

We first found this page on 2025-06-17 00:11:15 +0000. It was last re-indexed on 2025-09-22 07:13:37 +0000 and with a fetch interval of 2 days it will be fetched again in 0 days on 2025-09-26 or soon thereafter.

Last fetch returned code 503, Service Unavailable, the current page state is ACTIVE. We have tried to fetch the page 2 times.

Traffic Data for sunactcancer.com

If you are the owner of /sunactcancer.com and you want to remove this page from the search results, just use robots.txt

Similar Sites

CAR T-Cell Therapy for Refractory ITP: A New Autoimmune Solution | Sun

Explore how CAR T-cell therapy is revolutionizing treatment for refractory immune thrombocytopenia (ITP). Discover breakthroughs, real case results, and expert insights from SunAct – Advanced Cancer Therapies.
https://sunactcancer.com/reprogramming-immunity-can-car-t-cells-conquer-refractory-itp/ - Details - Similar

Double-Target CAR-T for Mantle Cell Lymphoma | SunAct

SunAct introduces dual-target CAR-T therapy for Mantle Cell Lymphoma targeting CD19 CD20 for deeper remission, faster cell manufacturing, and fewer relapses.
https://sunactcancer.com/double-target-car-t-a-promising-new-treatment-for-mantle-cell-lymphoma/ - Details - Similar

CAR‑T Cell Therapy in India: Cost, Process Hospitals

Explore CAR‑T Cell Therapy in India — learn about treatment cost, top hospitals, eligibility process. Get expert insights at SunAct Cancer Institute.
https://sunactcancer.com/car-t-cell-therapy-in-india-cost-success-rate-benefits-and-how-it-works/ - Details - Similar

Dual-Target CAR T-Cell Therapy for Childhood Rhabdomyosarcoma | SunAct

A promising new CAR T-cell therapy targeting FGFR4 and CD276 offers breakthrough hope for children with rhabdomyosarcoma. Learn how SunAct – Advanced Cancer Therapies is following this frontier in pediatric cancer care.
https://sunactcancer.com/a-new-horizon-in-childhood-cancer-treatment-dual-target-car-t-cells-show-promise-against-rhabdomyosarcoma/ - Details - Similar

More sites similar to CAR T-Cell Therapy for Refractory ITP: A New Autoimmune Solution | Sun...

Find Another Website

Search - Add URL

Sponsored Results

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less